Category Archives: Testosterone

Q: Is it okay for a man to have low levels of testosterone?

Dr Warren Deeves of Health Matters answers:

Decreasing levels of testosterone is often part of the ageing process, so its relatively common in older men.

However, testosterone deficiency can occur at any age due to conditions affecting the testicles, or the pituitary gland in the brain.

In adult males, testosterone deficiency can cause fatigue, infertility, reduced libido, erectile dysfunction, hot flashes, decreased muscle mass, development of breast tissue and loss of bone density.

Some describe it as the male menopause (but not in front of their wives for fear of retaliation).

A decrease in testosterone is usually a gradual process, so many men just assume their symptoms are a result of aging, and dont seek help.

If you have a deficiency, you can be treated with testosterone replacement therapy, however, the cause needs to be treated as well.

Too much testosterone can also be a problem.

It is uncommon to have high testosterone levels naturally, but this can be caused by adrenal or testicular tumours.

More often than not, high levels of testosterone are seen in people using anabolic steroids or prescription testosterone obtained illegally.

The symptoms may include heart or liver problems, high blood pressure, acne, aggression, infertility, insomnia, prostate enlargement and unexplained weight gain.

So in summary, we need to find the happy medium between too little or too much testosterone.

All those new moustaches you see in Movember are most likely due to normal testosterone levels, provided its not on a woman.

Read the original here:
Doctor On Call: Should you be concerned about your testosterone levels? - North Coast Courier

New York, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Asia Pacific Transdermal Drug Delivery System Market Forecast to 2027 COVID-19 Impact and Analysis by Type ; Application ; End User" - https://www.reportlinker.com/p05953751/?utm_source=GNW However, the drug delivery systems and drug failure and recalls of transdermal drug delivery systems hinder the growth of the market.China in the largest market for transdermal drug delivery system owing to increasing investment in R&D for the development of the innovative of new drug delivery systems.The excessive population in China, coupled with the rising prevalence of chronic diseases is offering immense growth opportunities in the transdermal patches and semisolid products for the pain management market.

However, considering the geographic and economic operations between Asian countries and China, the countries are expected to witness challenge of COVID-19.The outbreak of disease has badly affected supply chain, and led to shortage of healthcare supplies in the region.

Moreover, domestic start-ups backed by international funding have already started witnessing back out from investors putting the development of the products in jeopardy.The Asia Pacific transdermal drug delivery system market, based on type, is segmented into transdermal patch and transdermal semisolids.The transdermal patch segment is further sub segmented into drug-in-adhesive patches, matrix patches, reservoir membrane patches and micro needle patches.

The transdermal semisolids segment is further sub segmented into gels, ointments and sprays.The transdermal patch segment held the largest share of the market in 2019 and it is anticipated to register the highest CAGR in the market during the forecast period.

The Asia Pacific transdermal drug delivery system market, based on application, is segmented into cardiovascular diseases, central nervous system disorders, pain management, hormonal applications and other applications.The hormonal segment is further sub segmented into transdermal estrogen therapy, testosterone replacement therapy.

The pain management segment held the largest share of the market in 2019, and continued to register the highest CAGR during the forecast period. Based on end user, the transdermal drug delivery system market has been segmented into hospitals and clinics, home care settings, and other end users. The hospitals and clinics segment held the largest share of the market in 2019, on the other hand, home care settings is expected to register the highest CAGR in the market during the forecast period.A few major primary and secondary sources referred to in the process of preparing the report on the transdermal drug delivery system market are the World Health Organization, International Diabetes Federation, and Centre for Disease Prevention and Control.Read the full report: https://www.reportlinker.com/p05953751/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Excerpt from:
The Asia Pacific transdermal drug delivery system market is expected to reach US$ 1,736.02 million by 2027 from US$ 1,199.69 million in 2019 -...

Male menopause refers to the hormonal imbalance or hormonal changes in the males due to which there is a reduction in the testosterone levels in the males. There are various symptoms of male menopause. Some of the symptoms include low energy, increasing body fat, decreasing bone density, erectile dysfunction, infertility, etc. There are many other changes associated with the testosterone level changes. Some of the major changes observed in males are a growth of the muscle mass, lowering of voice and changes related to sexual functioning. The male menopause can be treated by changing the lifestyle habits or it can be treated by taking testosterone replacement therapy. Healthy lifestyle habits such as taking a healthy diet. Having proper nap etc. can treat the male menopause treatment market.

Increasing research and developmental activities is one of the major factor driving the growth of male menopause treatment market. The rate of smoking is increasing, which can lead to hormonal imbalance, increasing the growth of the male menopause treatment market. Large intake of drugs and alcohol is another important factor, which can be responsible for the reduction of testosterone level and is expected to increase the growth of male menopause treatment market. Increasing adoption of poor lifestyle habits such as a high intake of junk food, lack of exercise, etc. can be responsible for increasing the growth of male menopause treatment market. Increasing stress due to daily hectic routine can also increase the growth of male menopause treatment market. Other factors, such as increasing healthcare awareness, technological advancements leading to better diagnostic rates, increasing disposable income, modernization of the Indian society, etc. can be responsible for the significant growth of male menopause treatment market.

There are various side effects of male menopause treatment drugs, which can hinder the growth of male menopause treatment market. Lack of awareness in some of the developing regions can restrain the growth of male menopause treatment market.

To remain ahead of your competitors, request for a sample[emailprotected]

https://www.persistencemarketresearch.com/samples/28771

The global Male Menopause Treatment market is segmented on basis of drug type, Source of administration, distribution channel and geographic region:

Based on the drug type, the Male Menopause Treatment has been divided into testosterone supplements and vitamin supplements. Testosterone supplements can be given in various forms and are expected to hold the largest revenue share in the male menopause treatment market. Testosterone replacement therapy is the most common therapy, used for the treatment of male menopause treatment market. Amongst all the testosterone supplements, DHEA and D-Aspartic acid are expected to hold the maximum revenue share in the male menopause treatment market. Based on the route of administration, the male menopause treatment market has been divided into oral administration and subcutaneous administration. Oral route of administration is expected to hold the maximum revenue share in the male menopause treatment market as it is the most common form of administration used by the male patients. Based on the distribution channel, the male menopause treatment has been divided into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. Drug stores and hospital pharmacies are expected to hold the maximum revenue share in the male menopause treatment market.

To receive extensive list of important regions, Request Methodology here @

https://www.persistencemarketresearch.com/methodology/28771

On the basis of geography, the global Male Menopause Treatment market is studied and divided into a few key regions such as North America, Latin America, Europe, Asia, Middle East & Africa and Oceania. North America is expected to hold a large revenue share in global Male Menopause Treatment market because of the presence of a large number of research and developmental activities and availability of technological advancement in the field of healthcare. Europe is expected to hold the second largest market share because of the presence of the large population. The Asia Pacific can also show a large revenue share in the Male Menopause Treatment market because of the increasing healthcare awareness

There are many companies manufacturing Male Menopause Treatment drugs. Some of the big pharmaceutical companies involved in the manufacture of Male Menopause Treatment drugs are Thermofisher Scientific Inc., Abbott, Sun Pharmaceuticals Industries Ltd., Perrigo Company plc, Bayer AG and many other companies.

You Can Request for TOC[emailprotected]

https://www.persistencemarketresearch.com/toc/28771

Explore Extensive Coverage of PMR`s

Life Sciences & Transformational HealthLandscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Naved BegPersistence Market ResearchAddress 305 Broadway, 7th Floor, New York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Websitehttps://www.persistencemarketresearch.com

Original post:
The Male Menopause Treatment Market to witness extrapolation in the next decade - The Haitian-Caribbean News Network

Oct 2020, Latest release fromWMR -Testosterone Replacement Therapy MarketResearch Report 2020-2026(by Product Type, End-User/Application, and Regions/Countries)evaluates each segment of the Premium Testosterone Replacement Therapy market in detail so that readers can be guided about future opportunities and high-profit areas of the industry. It includespresents an encyclopedic study of importantmarket dynamics, including Market Size, Share, Growth Initiators, Trends, Obstacles, Challenges, and opportunities.

The primary objective of theTestosterone Replacement Therapy marketreport is to provide insights regarding opportunities in the market that are supporting the transformation of global businesses associated with Testosterone Replacement Therapy. This report also provides an estimation of the Testosterone Replacement Therapy market size and corresponding revenue forecasts carried out in terms of US$. It also offers actionable insights based on future trends in the Testosterone Replacement Therapy market. Furthermore, new and emerging players in the global Testosterone Replacement Therapy market can make use of the information presented in the study for effective business decisions, which will provide momentum to their businesses as well as the global Testosterone Replacement Therapy market.

Download the FREE sample of this Reporthttps://www.worldwidemarketreports.com/sample/204548

The Major Players covered in this Testosterone Replacement Therapy Market reports are-AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals

The outbreak of the pandemicCOVID-19changed the market scenario on the global platform. Many of the regions are facing the biggest economic crisis owing to the lockdowns that were implemented due to the outspread of the coronavirus infection. As the only solution that has been found to contracting this disease is social distancing many countries have implemented strong regulations in regards to people gatherings. Owing to this many of the businesses are working with only 30% of its employees thus not able to bring the maximum production.

Thiscan affect the global economy in 3 main ways: by directly affecting production and demand, by creating supply chain and market disturbance, and by its financial impact on firms and financial markets.

Get the Latest Updates as well How Covid-19 Affected the Testosterone Replacement Therapy Market in one report:https://www.worldwidemarketreports.com/covidimpact/204548

Market Attributes

Details

The market size value in 2020

USDXX Million

The revenue forecast in 2026

USDXX Million

Growth Rate

CAGR of XX % from 2020 to 2026

Report coverage

Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, And Trends

Country scope

U.S., Canada, Mexico, U.K., Germany, France, Italy, China, India, Japan, Brazil, Argentina, Saudi Arabia, South Africa

The scope of the report extends from market scenarios to price comparisons between key players, costs, and benefits in specific market regions. Numerical data is backed up with statistical tools such asSWOT analysis, BCG matrix, SCOT analysis, and PESTLE analysis. Statistics are presented in graphical format for a clear understanding of facts and figures.

Do you have any Query or any customization with this report, please get in touch with our business experts at:https://www.worldwidemarketreports.com/quiry/204548

Contact Us:

Mr. ShahWorldwide Market ReportsSeattle, WA 98154,U.S.Email: sales@worldwidemarketreports.com

Read the original:
COVID-19 to Testosterone Replacement Therapy Market Inelastic in Near Term, Projects WMR : AbbVie, Endo International, Eli lilly, Pfizer -...

Overview Of Testosterone Replacement Therapy Industry 2020-2026:

This has brought along several changes in This report also covers the impact of COVID-19 on the global market.

The Testosterone Replacement Therapy Market analysis summary by Reports Insights is a thorough study of the current trends leading to this vertical trend in various regions. Research summarizes important details related to market share, market size, applications, statistics and sales. In addition, this study emphasizes thorough competition analysis on market prospects, especially growth strategies that market experts claim.

Testosterone Replacement Therapy Market competition by top manufacturers as follow: , Endo International, AbbVie, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals,,

Get a Sample PDF copy of the report @ https://reportsinsights.com/sample/75680

The global Testosterone Replacement Therapy market has been segmented on the basis of technology, product type, application, distribution channel, end-user, and industry vertical, along with the geography, delivering valuable insights.

The Type Coverage in the Market are: GelsInjectionsPatchesOthers

Market Segment by Applications, covers:HospitalsClinicsOthers

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaRest of Asia PacificCentral & South AmericaMiddle East & Africa

Major factors covered in the report:

To get this report at a profitable rate.: https://reportsinsights.com/discount/75680

The analysis objectives of the report are:

Our report offers:

Market share assessments for the regional and country level segments. Market share analysis of the top industry players. Strategic recommendations for the new entrants. Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets. Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations). Strategic recommendations in key business segments based on the market estimations. Competitive landscaping mapping the key common trends. Company profiling with detailed strategies, financials, and recent developments. Supply chain trends mapping the latest technological advancements.

Access full Report Description, TOC, Table of Figure, Chart, etc. @ https://reportsinsights.com/industry-forecast/Testosterone-Replacement-Therapy-75680

About US:

Reports Insights is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.

Contact US:

:(US) +1-214-272-0234

:(APAC) +91-7972263819

Email:[emailprotected]

Sales:[emailprotected]

See the article here:
Testosterone Replacement Therapy Market: Technological Advancement & Growth Analysis with Forecast to 2026 - Eurowire

Final Report will add the analysis of the impact of COVID-19 on this industry.

November 2020:

The recent report entitled Global Testosterone Replacement Therapy Market Size, Status and Forecast 2020-2027 offered by Coherent Market Insights, comprises a comprehensive investigation into the geographic landscape, industry size and business revenue estimate. In addition, the report also highlights the challenges that hinder market growth and the expansion strategies employed by leading companies in the Testosterone Replacement Therapy market.

This is the most recent report that includes the effects of COVID-19 on the functioning of the market. It is well known that some changes, for the worse, were managed by the pandemic in all industries. The current scenario of the business sector and the impact of the pandemic on the industrys past and future are addressed in this report.

Get a free sample copy of this [emailprotected]: https://www.coherentmarketinsights.com/insight/request-sample/2024

In the market segmentation by manufacturers, the report covers the following companies:

AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.

Detailed Segmentation:

By Active Ingredient TypeTestosteroneMethyl TestosteroneTestosterone UndecanoateTestosterone EnanthateTestosterone CypionateBy Route of AdministrationInjectablesParenteral

Testosterone Replacement Therapy Market regional analysis includes:

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia and Australia)

Europe (Turkey, Germany, Russia, United Kingdom, Italy, France, etc.)

North America (United States, Mexico and Canada).

South America (Brazil etc.)

Middle East and Africa (GCC countries and Egypt).

The survey provides answers to the following key questions:

What is the expected growth rate of the Testosterone Replacement Therapy market? How big will the market be for the forecast period, 2020-2027?

What are the main drivers responsible for transforming the sectors trajectory?

Who are the main suppliers that dominate the Testosterone Replacement Therapy industry in different regions? What are the winning strategies to stay ahead of the competition?

What are the market trends that entrepreneurs can trust in the coming years?

What are the threats and challenges expected to restrict the progress of the industry in different countries?

What are the main opportunities that business owners can take advantage of for the 2020-2027 forecast period?

Why choose CMI?

Need a discount?

Note: *The discount is offered on the Standard Price of the report.

Ask for the discount @ https://www.coherentmarketinsights.com/insight/request-discount/2024

Regional Demand Estimation and Forecast

Pre-commodity price volatility

Analysis of technological updates

Analysis of Location Quotients

Competitive analysis

Matrix of product mix

Supplier management

Cost-benefit analysis

Supply chain optimization analysis

Patent Analysis

Carbon footprint analysis

R&D analysis

Fusions and acquisitions

Contact us for any query or to get a personalized [emailprotected]: https://www.coherentmarketinsights.com/insight/request-customization/2024

NOTE:Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details

Interested about who is winning the race of COVID-19 Vaccine. Coherent Market Insights (CMI)

providesCOVID-19 Vaccine Trackerfor all the latest updates about COVID-19 Vaccine.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Contact Us:

Mr. ShahCoherent Market Insights1001 4th Ave,#3200Seattle, WA 98154Tel: +1-206-701-6702Email: [emailprotected]

Read more from the original source:
Testosterone Replacement Therapy Market Report 2020 Growth of Industry, Manufacturing, Value, Consumption, Status and Forecast for 2027 -...

The global Testosterone Replacement Therapy market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future status of the global Testosterone Replacement Therapy market. The research study comes out as a compilation of useful guidelines for players to secure a position of strength in the global Testosterone Replacement Therapy market. The authors of the report profile leading companies of the global Testosterone Replacement Therapy market, such as AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals They provide details about important activities of leading players in the competitive landscape.

The report predicts the size of the global Testosterone Replacement Therapy market in terms of value and volume for the forecast period 2019-2026. As per the analysis provided in the report, the global Testosterone Replacement Therapy market is expected to rise at a CAGR of XX % between 2019 and 2026 to reach a valuation of US$ XX million/billion by the end of 2026. In 2018, the global Testosterone Replacement Therapy market attained a valuation of US$_ million/billion. The market researchers deeply analyze the global Testosterone Replacement Therapy industry landscape and the future prospects it is anticipated to create.

This publication includes key segmentations of the global Testosterone Replacement Therapy market on the basis of product, application, and geography (country/region). Each segment included in the report is studied in relation to different factors such as consumption, market share, value, growth rate, and production.

Get Sample Copy of This Report:https://www.qyresearch.com/sample-form/form/1510148/global-testosterone-replacement-therapy-industry

The comparative results provided in the report allow readers to understand the difference between players and how they are competing against each other. The research study gives a detailed view of current and future trends and opportunities of the global Testosterone Replacement Therapy market. Market dynamics such as drivers and restraints are explained in the most detailed and easiest manner possible with the use of tables and graphs. Interested parties are expected to find important recommendations to improve their business in the global Testosterone Replacement Therapy market.

Readers can understand the overall profitability margin and sales volume of various products studied in the report. The report also provides the forecasted as well as historical annual growth rate and market share of the products offered in the global Testosterone Replacement Therapy market. The study on end-use application of products helps to understand the market growth of the products in terms of sales.

Global Testosterone Replacement Therapy Market by Product: , Gels, Injections, Patches, Other Market

Global Testosterone Replacement Therapy Market by Application: Hospitals, Clinics, Others

The report also focuses on the geographical analysis of the global Testosterone Replacement Therapy market, where important regions and countries are studied in great detail.

Global Testosterone Replacement Therapy Market by Geography:

Methodology

Our analysts have created the report with the use of advanced primary and secondary research methodologies.

As part of primary research, they have conducted interviews with important industry leaders and focused on market understanding and competitive analysis by reviewing relevant documents, press releases, annual reports, and key products.

For secondary research, they have taken into account the statistical data from agencies, trade associations, and government websites, internet sources, technical writings, and recent trade information.

Enquire For Customization in the Report:https://www.qyresearch.com/customize-request/form/1510148/global-testosterone-replacement-therapy-industry

Key questions answered in the report:

Table Of Contents:

Table of Contents 1 Report Overview1.1 Research Scope1.2 Top Testosterone Replacement Therapy Manufacturers Covered: Ranking by Revenue1.3 Market Segment by Type1.3.1 Global Testosterone Replacement Therapy Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)1.3.2 Gels1.3.3 Injections1.3.4 Patches1.3.5 Other1.4 Market Segment by Application1.4.1 Global Testosterone Replacement Therapy Consumption by Application: 2015 VS 2020 VS 20261.4.2 Hospitals1.4.3 Clinics1.4.4 Others1.5 Study Objectives1.6 Years Considered 2 Global Market Perspective2.1 Global Testosterone Replacement Therapy Revenue (2015-2026)2.1.1 Global Testosterone Replacement Therapy Revenue (2015-2026)2.1.2 Global Testosterone Replacement Therapy Sales (2015-2026)2.2 Testosterone Replacement Therapy Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 20262.2.1 Global Testosterone Replacement Therapy Sales by Regions (2015-2020)2.2.2 Global Testosterone Replacement Therapy Revenue by Regions (2015-2020)2.3 Global Top Testosterone Replacement Therapy Regions (Countries) Ranking by Market Size2.4 Testosterone Replacement Therapy Industry Trends2.4.1 Testosterone Replacement Therapy Market Top Trends2.4.2 Market Drivers2.4.3 Testosterone Replacement Therapy Market Challenges 2.4.4 Porters Five Forces Analysis2.4.5 Primary Interviews with Key Testosterone Replacement Therapy Players: Views for Future 3 Competitive Landscape by Manufacturers3.1 Global Top Testosterone Replacement Therapy Manufacturers by Sales (2015-2020)3.1.1 Global Testosterone Replacement Therapy Sales by Manufacturers (2015-2020)3.1.2 Global Testosterone Replacement Therapy Sales Market Share by Manufacturers (2015-2020)3.1.3 Global 5 and 10 Largest Manufacturers by Testosterone Replacement Therapy Sales in 20193.2 Global Top Manufacturers Testosterone Replacement Therapy by Revenue3.2.1 Global Testosterone Replacement Therapy Revenue by Manufacturers (2015-2020)3.2.2 Global Testosterone Replacement Therapy Revenue Share by Manufacturers (2015-2020)3.2.3 Global Testosterone Replacement Therapy Market Concentration Ratio (CR5 and HHI)3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Testosterone Replacement Therapy as of 2019)3.4 Global Testosterone Replacement Therapy Average Selling Price (ASP) by Manufacturers3.5 Key Manufacturers Testosterone Replacement Therapy Plants/Factories Distribution and Area Served3.6 Date of Key Manufacturers Enter into Testosterone Replacement Therapy Market3.7 Key Manufacturers Testosterone Replacement Therapy Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type4.1 Global Testosterone Replacement Therapy Historic Market Review by Type (2015-2020)4.1.2 Global Testosterone Replacement Therapy Sales Market Share by Type (2015-2020)4.1.3 Global Testosterone Replacement Therapy Revenue Market Share by Type (2015-2020)4.1.4 Testosterone Replacement Therapy Price by Type (2015-2020)4.1 Global Testosterone Replacement Therapy Market Estimates and Forecasts by Type (2021-2026)4.2.2 Global Testosterone Replacement Therapy Sales Forecast by Type (2021-2026)4.2.3 Global Testosterone Replacement Therapy Revenue Forecast by Type (2021-2026)4.2.4 Testosterone Replacement Therapy Price Forecast by Type (2021-2026) 5 Global Testosterone Replacement Therapy Market Size by Application5.1 Global Testosterone Replacement Therapy Historic Market Review by Application (2015-2020)5.1.2 Global Testosterone Replacement Therapy Sales Market Share by Application (2015-2020)5.1.3 Global Testosterone Replacement Therapy Revenue Market Share by Application (2015-2020)5.1.4 Testosterone Replacement Therapy Price by Application (2015-2020)5.2 Global Testosterone Replacement Therapy Market Estimates and Forecasts by Application (2021-2026)5.2.2 Global Testosterone Replacement Therapy Sales Forecast by Application (2021-2026)5.2.3 Global Testosterone Replacement Therapy Revenue Forecast by Application (2021-2026)5.2.4 Testosterone Replacement Therapy Price Forecast by Application (2021-2026) 6 North America6.1 North America Testosterone Replacement Therapy Breakdown Data by Company6.2 North America Testosterone Replacement Therapy Breakdown Data by Type6.3 North America Testosterone Replacement Therapy Breakdown Data by Application6.4 North America Testosterone Replacement Therapy Breakdown Data by Countries6.4.1 North America Testosterone Replacement Therapy Sales by Countries6.4.2 North America Testosterone Replacement Therapy Revenue by Countries6.4.3 U.S.6.4.4 Canada 7 Europe7.1 Europe Testosterone Replacement Therapy Breakdown Data by Company7.2 Europe Testosterone Replacement Therapy Breakdown Data by Type7.3 Europe Testosterone Replacement Therapy Breakdown Data by Application7.4 Europe Testosterone Replacement Therapy Breakdown Data by Countries7.4.1 Europe Testosterone Replacement Therapy Sales by Countries7.4.2 Europe Testosterone Replacement Therapy Revenue by Countries7.4.3 Germany7.4.4 France7.4.5 U.K.7.4.6 Italy7.4.7 Russia 8 Asia Pacific8.1 Asia Pacific Testosterone Replacement Therapy Breakdown Data by Company8.2 Asia Pacific Testosterone Replacement Therapy Breakdown Data by Type8.3 Asia Pacific Testosterone Replacement Therapy Breakdown Data by Application8.4 Asia Pacific Testosterone Replacement Therapy Breakdown Data by Regions8.4.1 Asia Pacific Testosterone Replacement Therapy Sales by Regions8.4.2 Asia Pacific Testosterone Replacement Therapy Revenue by Regions8.4.3 China8.4.4 Japan8.4.5 South Korea8.4.6 India8.4.7 Australia8.4.8 Taiwan8.4.9 Indonesia8.4.10 Thailand8.4.11 Malaysia8.4.12 Philippines8.4.13 Vietnam 9 Latin America9.1 Latin America Testosterone Replacement Therapy Breakdown Data by Company9.2 Latin America Testosterone Replacement Therapy Breakdown Data by Type9.3 Latin America Testosterone Replacement Therapy Breakdown Data by Application9.4 Latin America Testosterone Replacement Therapy Breakdown Data by Countries9.4.1 Latin America Testosterone Replacement Therapy Sales by Countries9.4.2 Latin America Testosterone Replacement Therapy Revenue by Countries9.4.3 Mexico9.4.4 Brazil9.4.5 Argentina 10 Middle East and Africa10.1 Middle East and Africa Testosterone Replacement Therapy Breakdown Data by Type10.2 Middle East and Africa Testosterone Replacement Therapy Breakdown Data by Application10.3 Middle East and Africa Testosterone Replacement Therapy Breakdown Data by Countries10.3.1 Middle East and Africa Testosterone Replacement Therapy Sales by Countries10.3.2 Middle East and Africa Testosterone Replacement Therapy Revenue by Countries10.3.3 Turkey10.3.4 Saudi Arabia10.3.5 U.A.E 11 Company Profiles11.1 AbbVie11.1.1 AbbVie Corporation Information11.1.2 AbbVie Business Overview and Total Revenue (2019 VS 2018)11.1.3 AbbVie Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.1.4 AbbVie Testosterone Replacement Therapy Products and Services11.1.5 AbbVie SWOT Analysis11.1.6 AbbVie Recent Developments11.2 Endo International11.2.1 Endo International Corporation Information11.2.2 Endo International Business Overview and Total Revenue (2019 VS 2018)11.2.3 Endo International Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.2.4 Endo International Testosterone Replacement Therapy Products and Services11.2.5 Endo International SWOT Analysis11.2.6 Endo International Recent Developments11.3 Eli lilly11.3.1 Eli lilly Corporation Information11.3.2 Eli lilly Business Overview and Total Revenue (2019 VS 2018)11.3.3 Eli lilly Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.3.4 Eli lilly Testosterone Replacement Therapy Products and Services11.3.5 Eli lilly SWOT Analysis11.3.6 Eli lilly Recent Developments11.4 Pfizer11.4.1 Pfizer Corporation Information11.4.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)11.4.3 Pfizer Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.4.4 Pfizer Testosterone Replacement Therapy Products and Services11.4.5 Pfizer SWOT Analysis11.4.6 Pfizer Recent Developments11.5 Actavis (Allergan)11.5.1 Actavis (Allergan) Corporation Information11.5.2 Actavis (Allergan) Business Overview and Total Revenue (2019 VS 2018)11.5.3 Actavis (Allergan) Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.5.4 Actavis (Allergan) Testosterone Replacement Therapy Products and Services11.5.5 Actavis (Allergan) SWOT Analysis11.5.6 Actavis (Allergan) Recent Developments11.6 Bayer11.6.1 Bayer Corporation Information11.6.2 Bayer Business Overview and Total Revenue (2019 VS 2018)11.6.3 Bayer Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.6.4 Bayer Testosterone Replacement Therapy Products and Services11.6.5 Bayer SWOT Analysis11.6.6 Bayer Recent Developments11.7 Novartis11.7.1 Novartis Corporation Information11.7.2 Novartis Business Overview and Total Revenue (2019 VS 2018)11.7.3 Novartis Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.7.4 Novartis Testosterone Replacement Therapy Products and Services11.7.5 Novartis SWOT Analysis11.7.6 Novartis Recent Developments11.8 Teva11.8.1 Teva Corporation Information11.8.2 Teva Business Overview and Total Revenue (2019 VS 2018)11.8.3 Teva Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.8.4 Teva Testosterone Replacement Therapy Products and Services11.8.5 Teva SWOT Analysis11.8.6 Teva Recent Developments11.9 Mylan11.9.1 Mylan Corporation Information11.9.2 Mylan Business Overview and Total Revenue (2019 VS 2018)11.9.3 Mylan Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.9.4 Mylan Testosterone Replacement Therapy Products and Services11.9.5 Mylan SWOT Analysis11.9.6 Mylan Recent Developments11.10 Upsher-Smith11.10.1 Upsher-Smith Corporation Information11.10.2 Upsher-Smith Business Overview and Total Revenue (2019 VS 2018)11.10.3 Upsher-Smith Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.10.4 Upsher-Smith Testosterone Replacement Therapy Products and Services11.10.5 Upsher-Smith SWOT Analysis11.10.6 Upsher-Smith Recent Developments11.11 Ferring Pharmaceuticals11.11.1 Ferring Pharmaceuticals Corporation Information11.11.2 Ferring Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)11.11.3 Ferring Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.11.4 Ferring Pharmaceuticals Testosterone Replacement Therapy Products and Services11.11.5 Ferring Pharmaceuticals SWOT Analysis11.11.6 Ferring Pharmaceuticals Recent Developments11.12 Kyowa Kirin11.12.1 Kyowa Kirin Corporation Information11.12.2 Kyowa Kirin Business Overview and Total Revenue (2019 VS 2018)11.12.3 Kyowa Kirin Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.12.4 Kyowa Kirin Testosterone Replacement Therapy Products and Services11.12.5 Kyowa Kirin SWOT Analysis11.12.6 Kyowa Kirin Recent Developments11.13 Acerus Pharmaceuticals11.13.1 Acerus Pharmaceuticals Corporation Information11.13.2 Acerus Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)11.13.3 Acerus Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.13.4 Acerus Pharmaceuticals Testosterone Replacement Therapy Products and Services11.13.5 Acerus Pharmaceuticals SWOT Analysis11.13.6 Acerus Pharmaceuticals Recent Developments 12 Supply Chain and Sales Channels Analysis 12.1 Supply Chain Analysis 12.2 Sales Channels Analysis12.2.1 Testosterone Replacement Therapy Sales Channels12.2.2 Testosterone Replacement Therapy Distributors12.3 Testosterone Replacement Therapy Customers 13 Estimates and Projections by Regions (2021-2026)13.1 Global Testosterone Replacement Therapy Sales Forecast (2021-2026)13.1.1 Global Testosterone Replacement Therapy Sales Forecast by Regions (2021-2026)13.1.2 Global Testosterone Replacement Therapy Revenue Forecast by Regions (2021-2026) 13.2 North America Market Size Forecast (2021-2026)13.2.1 North America Testosterone Replacement Therapy Sales Forecast (2021-2026)13.2.2 North America Testosterone Replacement Therapy Revenue Forecast (2021-2026)13.2.3 North America Testosterone Replacement Therapy Size Forecast by County (2021-2026) 13.3 Europe Market Size Forecast (2021-2026)13.3.1 Europe Testosterone Replacement Therapy Sales Forecast (2021-2026)13.3.2 Europe Testosterone Replacement Therapy Revenue Forecast (2021-2026)13.3.3 Europe Testosterone Replacement Therapy Size Forecast by County (2021-2026) 13.4 Asia Pacific Market Size Forecast (2021-2026)13.4.1 Asia Pacific Testosterone Replacement Therapy Sales Forecast (2021-2026)13.4.2 Asia Pacific Testosterone Replacement Therapy Revenue Forecast (2021-2026)13.4.3 Asia Pacific Testosterone Replacement Therapy Size Forecast by Region (2021-2026) 13.5 Latin America Market Size Forecast (2021-2026)13.5.1 Latin America Testosterone Replacement Therapy Sales Forecast (2021-2026)13.5.2 Latin America Testosterone Replacement Therapy Revenue Forecast (2021-2026)13.5.3 Latin America Testosterone Replacement Therapy Size Forecast by County (2021-2026) 13.6 Middle East and Africa Market Forecast13.6.1 Middle East and Africa Testosterone Replacement Therapy Sales Forecast (2021-2026)13.6.2 Middle East and Africa Testosterone Replacement Therapy Revenue Forecast (2021-2026)13.6.3 Middle East and Africa Testosterone Replacement Therapy Size Forecast by County (2021-2026) 14 Research Findings and Conclusion 15 Appendix15.1 Research Methodology15.1.1 Methodology/Research Approach15.1.2 Data Source15.2 Author Details15.3 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

See the article here:
Testosterone Replacement Therapy Market Overview, Development History And Forecast To Shared In Latest Research Report 2020-2026 |Endo International,...

As a child growing up in Brights Grove, Ont., Jessica Platt lived for hockey. For her, being on the ice was "when everything made sense."

But off the ice, it was a different story.

For years, Platt struggled with feeling as though she didn't fit in with the other boys, and hated being in the locker room.

By her teens, she would leave the game she loved, and nearlyseven years would pass before she played hockey again.

Platt, now of Kitchener, Ont., shares hertriumphs and struggles in a chapter of the new book, Everyday Hockey Heroes Volume II, by sports journalists Bob McKenzie and Jim Lang. Platt is the author ofthe chapter titled 'Simply A Hockey Player'.

"It took a lot for me to share my story like this," Platt told CBC Radio's Afternoon Drive. "I typically like to focus on the positive aspects, but I had to highlight some of the negative things that I had been through in my life and had to overcome. So it was difficult to write it."

In the book, Platt looks back on the seven years she spent away from hockey. She moved from Brights Groveto Waterloo, Ont. for university, but not before undergoing hormone replacement therapy (HRT). The physical changes that accompanied the therapy meant a significant loss in her athletic ability.

"A lot of people think that to be a transgender woman playing sportsyou just simply have to identify as a woman," Platt said. "But at the elite levels, you have to undergo medical intervention. And the lack of testosterone in your bodydefinitely decreases your speed, your strength, pretty much everything. You have to get used to a new normal."

After beginning hormone replacement therapy and eventually transitioning her gender, Platt played professional for the Toronto Furies of the now-defunct Canadian Women's Hockey League team.

In 2018, she became the first openly transgender woman in North American professional hockey.

Despite having supportive teammates who she could trust, Platt reflected on the nerve-wracking experience of coming out to coaches, staff, and eventually the entire league.

"Absolutely terrifying," Platt recalled of the experience."I was petrified to potentially feel like I didn't belong in the dressing room again, like I had fought so long for growing up."

"But thankfully, I got nothing but positive responses and support from my teammates and my coaches. And that was truly incredible."

The book Everyday Hockey Heroes Volume IIwas released earlier this week by Simon & Schuster. Take a listen belowto Afternoon Drive'sfull interview with Jessica Platt.

Afternoon Drive8:24Transgender hockey player shares experience in new book

Link:
Triumphs and hardships as pro hockey's 1st openly transgender woman - CBC.ca

Transparency Market Research (TMR)has published a new report titled, Testosterone Replacement Therapy Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20192027.According to the report, the globalTestosterone Replacement Therapy marketwas valued atUS$ 1,613.7 Mnin2018and is projected to expand at a CAGR of4.4%from2019to2027.

Overview

Request Brochure for Report https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1097

Growing Awareness about Testosterone Replacement Therapy to Drive Market

Request for Analysis of COVID19 Impact on Testosterone Replacement Therapy Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1097

North America to Dominate Global Market

Buy Testosterone Replacement Therapy Market Report

https://www.transparencymarketresearch.com/checkout.php?rep_id=1097&ltype=S

Competitive Landscape

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Excerpt from:
Testosterone Replacement Therapy Market projected to expand at a CAGR of 4.4% from 2019 to 2027 - Eurowire

Sometimes people think of estrogen as a female hormone. However, all human bodies require estrogen to function correctly.

Estrogen is a hormone that naturally occurs in a persons body. Levels of estrogen that are too high or too low can cause a person to have health problems.

This article will discuss the role of estrogen in the male body, symptoms of high or low estrogen levels, and how people can treat irregular levels.

Estrogen is a sex hormone found in both males and females, although females have higher estrogen levels than males do.

The ovaries, testes, fat cells, and adrenal glands produce estrogen. It is important for female puberty and controlling the menstrual cycle. Estrogen is also important for the male reproductive system.

There are three types of estrogen:

Testosterone can be converted into estradiol using the enzyme aromatase. Estradiol is used by the male body for:

Estrogen also has other functions in the human body. It can help control cholesterol levels and maintain bone and heart health. It also affects mood, skin, and other tissues of the body.

The amount of estrogen a male should have will depend on their age and health history. According to the Endocrine Society, an adult male should have an estradiol level of 1040 picograms per milliliter (pg/mL) and an estrone level of 1050 pg/ml.

A person who is concerned about their levels of estrogen should speak to their doctor.

Although the male body needs estrogen to function correctly, too much estrogen can cause health problems.

Increased levels of estrogen can cause symptoms such as infertility, erectile dysfunction, and depression.

A person who is concerned about their estrogen levels should contact their doctor.

Low levels of estrogen in the male body can produce symptoms such as:

Researchers found that males with cardiovascular disease had lower levels of testosterone and estrogen.

Hypogonadism, a condition that can cause a decrease in sex hormones, can be a cause of low estrogen in males.

Further research is needed to confirm the symptoms that low estrogen can have on the male body.

Learn more about low estrogen here.

High levels of estrogen can cause a variety of problems in the male body. Symptoms of high estrogen levels in males include:

Increases in estrogen in males can also be an indicator of the following conditions:

Research into the effect of estrogen on migraines indicates that males with higher estrogen levels may be at higher risk of having migraines. However, researchers note that further study is required to confirm these findings.

A 2019 study into the link between high estrogen levels and diffuse cutaneous systemic sclerosis, an autoimmune disease, in males over 50 found that participants with significantly high estrogen levels had higher risk of cardiac involvement or death.

Aromatase excess syndrome and alcohol use disorder may be causes of increased estrogen in males.

Learn more about high estrogen here.

Reducing alcohol intake may cause a drop in estrogen levels.

There have also been studies suggesting that certain types of food may reduce estrogen levels. However, there is no definitive research to confirm the estrogen-lowering effects these foods have.

A male who wants to lower their estrogen levels should speak to their doctor. Certain medications are available that can help lower estrogen. They include selective estrogen receptor modulators and aromatase inhibitors.

A male who is experiencing symptoms of low estrogen should speak to their doctor about treatment options.

Hormone replacement therapy can help treat low estrogen levels in males caused by hypogonadism. A doctor may administer testosterone using a patch, an injection, a gel, or a product absorbed by the gums.

A person who experiences any symptoms of low or high estrogen levels should speak to their doctor.

The doctor may perform tests, such as blood test or urine sample test, in order to determine a persons estrogen levels. The doctor may then discuss what treatment options will suit the person best.

Levels of estrogen that are too high or too low can cause problems in males.

Low or high levels of estrogen can be indicators of underlying health problems.

A person who experiences symptoms of high or low estrogen levels should speak to their doctor.

Original post:
Estrogen in men: Symptoms of high and low levels, and more - Medical News Today